Literature DB >> 10444279

Regulation of the expression of Fc gamma receptor on circulating neutrophils and monocytes in Kawasaki disease.

K Nakatani1, S Takeshita, H Tsujimoto, Y Kawamura, H Kawase, I Sekine.   

Abstract

To investigate the regulation of Fc gamma receptor (Fc gamma R) expression on circulating phagocytes in Kawasaki disease (KD), we analysed the expressions of Fc gamma RI, II and III on neutrophils and monocytes in 20 patients with KD, 10 with a bacterial infection (BI), 10 with a viral infection (VI), and 10 healthy controls (HC) using flow cytometric analysis. The KD patients had a significantly higher level of Fc gamma RI expression on neutrophils, but not on monocytes, than the BI, VI and HC patients. Fc gamma RII expression on neutrophils was significantly higher in KD, BI and VI than HC, but there was no significant difference in Fc gamma RII expression among KD, BI and VI. Fc gamma RIII expression on neutrophils in KD was significantly lower than in VI and HC, but was higher on monocytes. A kinetic analysis of Fc gamma R expression in KD demonstrated the expression of Fc gamma RI and II on neutrophils to decline, but no remarkable change was observed in the monocytes, from the subacute phase through the convalescent phase. In addition, Fc gamma RIII expression on neutrophils increased, while Fc gamma RIII expression on monocytes decreased during the time course of KD. Fc gamma R expression in the acute phase of KD is thus characterized by markedly increased expression of Fc gamma RI on neutrophils, followed by a subsequent decrease, and decreased expression of Fc gamma RIII on neutrophils and increased expression of Fc gamma RIII on monocytes followed by a reverse kinetics during the clinical course. These findings are thus considered to reflect the functional up-regulation of neutrophils and monocytes in KD.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10444279      PMCID: PMC1905341          DOI: 10.1046/j.1365-2249.1999.00970.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  The role of bacterial lipopolysaccharide-bound neutrophils in the pathogenesis of Kawasaki disease.

Authors:  S Takeshita; K Nakatani; H Kawase; S Seki; M Yamamoto; I Sekine; S Yoshioka
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

2.  Febrile infection changes the expression of IgG Fc receptors and complement receptors in human neutrophils in vivo.

Authors:  L Leino; K Sorvajärvi; J Katajisto; M Laine; E M Lilius; T T Pelliniemi; A Rajamäki; P Silvoniemi; J Nikoskelainen
Journal:  Clin Exp Immunol       Date:  1997-01       Impact factor: 4.330

3.  The treatment of Kawasaki syndrome with intravenous gamma globulin.

Authors:  J W Newburger; M Takahashi; J C Burns; A S Beiser; K J Chung; C E Duffy; M P Glode; W H Mason; V Reddy; S P Sanders
Journal:  N Engl J Med       Date:  1986-08-07       Impact factor: 91.245

4.  Immunomodulation by intravenous immune globulin in Kawasaki disease.

Authors:  D Y Leung
Journal:  J Allergy Clin Immunol       Date:  1989-10       Impact factor: 10.793

5.  The effect of IFN-gamma and colony-stimulating factors on the expression of neutrophil cell membrane receptors.

Authors:  A M Buckle; N Hogg
Journal:  J Immunol       Date:  1989-10-01       Impact factor: 5.422

6.  [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children].

Authors:  T Kawasaki
Journal:  Arerugi       Date:  1967-03

7.  Immune thrombocytopenia and Fc receptor-mediated phagocyte function.

Authors:  A C Newland; M G Macey
Journal:  Ann Hematol       Date:  1994-08       Impact factor: 3.673

8.  Enhanced neutrophilic functions in mucocutaneous lymph node syndrome, with special reference to the possible role of increased oxygen intermediate generation in the pathogenesis of coronary thromboarteritis.

Authors:  Y Niwa; K Sohmiya
Journal:  J Pediatr       Date:  1984-01       Impact factor: 4.406

9.  Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease.

Authors:  D Y Leung; R S Cotran; E Kurt-Jones; J C Burns; J W Newburger; J S Pober
Journal:  Lancet       Date:  1989-12-02       Impact factor: 79.321

10.  High-dose intravenous gammaglobulin for Kawasaki disease.

Authors:  K Furusho; T Kamiya; H Nakano; N Kiyosawa; K Shinomiya; T Hayashidera; T Tamura; O Hirose; Y Manabe; T Yokoyama
Journal:  Lancet       Date:  1984-11-10       Impact factor: 79.321

View more
  7 in total

1.  Expression of IL-8 in Kawasaki disease.

Authors:  T Asano; S Ogawa
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

2.  The involvement of Fc gamma receptor gene polymorphisms in Kawasaki disease.

Authors:  M Biezeveld; J Geissler; M Merkus; I M Kuipers; J Ottenkamp; T Kuijpers
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

Review 3.  Nanomedicine for acute respiratory distress syndrome: The latest application, targeting strategy, and rational design.

Authors:  Qi Qiao; Xiong Liu; Ting Yang; Kexin Cui; Li Kong; Conglian Yang; Zhiping Zhang
Journal:  Acta Pharm Sin B       Date:  2021-05-07       Impact factor: 11.413

4.  Prevention of vascular inflammation by nanoparticle targeting of adherent neutrophils.

Authors:  Zhenjia Wang; Jing Li; Jaehyung Cho; Asrar B Malik
Journal:  Nat Nanotechnol       Date:  2014-02-23       Impact factor: 39.213

Review 5.  Neutrophils and Macrophages as Targets for Development of Nanotherapeutics in Inflammatory Diseases.

Authors:  Yujie Su; Jin Gao; Puneet Kaur; Zhenjia Wang
Journal:  Pharmaceutics       Date:  2020-12-17       Impact factor: 6.321

6.  Long-Term Hypermethylation of FcγR2B in Leukocytes of Patients with Kawasaki Disease.

Authors:  Ling-Sai Chang; Hong-Ren Yu; Chiao-Lun Chu; Kuang-Den Chen; Ying-Hsien Huang; Mindy Ming-Huey Guo; Ken-Pen Weng; Ho-Chang Kuo
Journal:  J Clin Med       Date:  2021-05-27       Impact factor: 4.241

7.  A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better?

Authors:  Wei Li; Xiufang He; Li Zhang; Zhouping Wang; Yanfei Wang; Huimei Lin; Jia Yuan; Xiaofei Xie; Youzhen Qin; Ping Huang
Journal:  Cardiovasc Ther       Date:  2021-06-18       Impact factor: 3.023

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.